Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Nations for Rock Climbing - 2Jason Kelce opens about wife Kylie Kelce's past pregnancy loss
- 3Rick Steves Doesn't Want You Overlooking This Food Spot While In France
- 4Vaccine makers raise concerns over US panel's shift away from hepatitis B shots for newborns
- 5Guns N' Roses 2026 Tour: How to get tickets, presale times, prices and more
- Vote in favor of your Number one kind of juice
- At least 18 Palestinians killed in latest clashes in Gaza
- What to know about voluntary chocolate recall
- 'Wow!' The eye surgery marathon that restored sight for some South Africans
- A Time of Careful Eating: Individual Tests in Nourishment
- The most effective method to Boost Benefits in Gold Speculation: Master Techniques and Tips
- New findings suggest atmosphere could exist on exoplanet TOI-561b
- Tear gas and arrests: Iranian regime continues crackdown on protesters amid economic unrest
- 2024 Watch Gathering: The Best Watches of the Year
